Log in to save to my catalogue

Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic La...

Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic La...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7f2193b7619e4891b18e753a21d724ed

Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients

About this item

Full title

Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients

Publisher

Switzerland: Frontiers Research Foundation

Journal title

Frontiers in neuroscience, 2019-04, Vol.13, p.344-344

Language

English

Formats

Publication information

Publisher

Switzerland: Frontiers Research Foundation

More information

Scope and Contents

Contents

The lack of biomarkers in Amyotrophic Lateral Sclerosis (ALS) makes it difficult to determine the stage of the disease in patients and, therefore, it delays therapeutic trials. Microvesicles (MVs) are possible biomarkers implicated in physiological and pathological functions, however, their role in ALS remains unclear. We investigated whether plasm...

Alternative Titles

Full title

Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7f2193b7619e4891b18e753a21d724ed

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7f2193b7619e4891b18e753a21d724ed

Other Identifiers

ISSN

1662-4548,1662-453X

E-ISSN

1662-453X

DOI

10.3389/fnins.2019.00344

How to access this item